Clinical trials recruiting in Bremerhaven, Germany

Phase breakdown

Conditions recruiting in Bremerhaven, Germany

Recruiting trials in Bremerhaven, Germany

• A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor for Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer at High Risk of Recurrence
  NCT06830720 · Phase: Not specified · Ages: 18 Years to 100 Years · Sex: All (male and female)
• Binimetinib Plus Encorafenib Real Life Investigation of Next Generation Melanoma Treatment
  NCT04045691 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• NeoAdj. Therapy Comparing Sacituzumab Govitecan (SG) vs. SG+Pembrolizumab in Low-risk, Triple-neg. EBC (ADAPT-TN-III)
  NCT06081244 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Female
• NeoAdjuvant Therapy With Trastuzumab-deruxtecan Versus Chemotherapy+Trastuzumab+Pertuzumab in HER2+ Early Breast Cancer
  NCT05704829 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Female
• PROOFS-Registry - Premenopausal Women With Breast Cancer Optimally Treated With OFS
  NCT05792150 · Phase: Not specified · Ages: 18 Years to 60 Years · Sex: Female
• Shift Workers' Health Behavior Action Program Across Europe
  NCT07631767 · Phase: Not applicable (e.g. observational or device study) · Ages: 21 Years and older · Sex: All (male and female)
• Single-Fraction Very Accelerated Partial Breast Irradiation (sfVAPBI)
  NCT07067437 · Phase: Not applicable (e.g. observational or device study) · Ages: 40 Years and older · Sex: Female

Common questions

How many clinical trials are recruiting in Bremerhaven, Germany?

7 recruiting trials have at least one study site in Bremerhaven, Germany.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.